By Yu Yan, Cover News Reporter

On March 16th, the 21st China International Exhibition on Clinical Laboratory Medicine and Blood Transfusion Equipment & Reagents and the 4th China International IVD Upstream Raw Material Manufacturing and Distribution Supply Chain Expo inaugurated at the Chongqing International Expo Center. Over 1300 in vitro diagnostic (IVD) enterprises from across the globe participated, exhibiting their most recent scientific research breakthroughs and technological innovations.

In vitro diagnostics refer to products and services that obtain clinical diagnostic information by analyzing human samples such as blood, bodily fluids, and tissues outside the human body, facilitating the diagnosis of diseases or assessment of bodily functions. Presently, IVD products are mainly composed of diagnostic equipment and reagents, both heavily integrated with artificial intelligence technologies.

This year's exhibition spans 130,000 square meters, divided into nine pavilions, featuring six exhibition zones: instruments and reagents, raw materials, components, consumables, general laboratory equipment, and supply chain management. More than 1300 IVD enterprises from nearly 20 countries and regions worldwide, covering the entire upstream, midstream, and downstream of the industry chain, are participating.

Scheduled for three days, the expo concurrently holds several professional forums including the 9th Creativity Voice China Experimental Medicine Conference and its sub-forums, the 11th China IVD Industry Development Congress, the 3rd China IVD Key Raw Materials and Components Forum, among others, presenting the latest IVD research outcomes to attending professionals.

Over 1300 in vitro diagnostic (IVD) companies from both home and abroad participate in the exhibition, representing the entire industry chain.